Achievement of Control of Severe Bronchial Asthma When Using Dupilumab

The aim of the study was to evaluate the possibility of achieving control of severe bronchial asthma (BA) using genetically engineered biological therapy with Dupilumab.   Materials and methods. The study included 32 patients with severe bronchial asthma (8 (25 %) men, mean age 58 [28; 65]) years, 2...

Full description

Bibliographic Details
Main Authors: O. V. Kazmerchuk, E. A. Sobko, I. V. Demko
Format: Article
Language:Russian
Published: SINAPS LLC 2024-11-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/1881